Home LiteratureArticle Details
PMID: 7657808 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

The Journal of clinical investigation ·Vol. 96 ·No. 3 ·1995-09-00 ·Pages 1328-35

Jacewicz MS, Acheson DW, Mobassaleh M, Donohue-Rolfe A, Balasubramanian KA, Keusch GT

Abstract

Differentiated villus intestinal epithelial cells express globotriaosylceramide, the Shiga-like toxin 1 (SLT-1) receptor, and are sensitive to toxin-mediated cytotoxicity, whereas undifferentiated crypt cells neither express Gb3 nor respond to toxin. To investigate if SLT-1 receptors are maturationally regulated in human intestinal cells, we examined the effect of butyrate, a known transcriptional regulator of differentiation genes in many cell types, using cultured colonic cancer-derived epithelial cell lines. Exposure to butyrate increased villus cell marker enzymes such as alkaline phosphatase, sucrase, and lactase, expression of toxin receptors, and sensitivity to SLT-1 in villus-like CaCo-2A and HT-29 cells. These effects were reversibly inhibited by preincubation of CaCo-2A cells with actinomycin D or cycloheximide. Butyrate-treated CaCo-2A cells unable to bind fluoresceinated SLT-1 B subunit were undifferentiated as assessed by alkaline phosphatase activity. HT-29 cells induced to differentiate by another signal, glucose deprivation, upregulated receptor content and response to toxin. Crypt-like T-84 cells responded to butyrate with a modest increase in alkaline phosphatase and toxin binding, but no induction of sucrase or lactase, and no change in sensitivity to toxin. The results demonstrate that expression of SLT-1 toxin receptors and toxin sensitivity are coregulated with cellular differentiation in cultured intestinal cells.

MeSH Terms
Adenocarcinoma Bacterial Toxins/isolation & purification,metabolism,toxicity Butyrates/pharmacology Butyric Acid Cell Line Cell Survival/drug effects Colonic Neoplasms Cycloheximide/pharmacology Dactinomycin/pharmacology Enterotoxins/metabolism Epithelium/metabolism Flow Cytometry Gene Expression Regulation, Neoplastic/drug effects Glycolipids/biosynthesis Humans Kinetics Receptors, Cell Surface/biosynthesis Shiga Toxin 1 Time Factors Transcription, Genetic/drug effects Trihexosylceramides/biosynthesis Tumor Cells, Cultured
Chemicals
Bacterial Toxins Butyrates Enterotoxins Glycolipids Receptors, Cell Surface Shiga Toxin 1 Shiga-like toxin receptor Trihexosylceramides Butyric Acid Dactinomycin globotriaosylceramide Cycloheximide
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jacewicz M S
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Acheson D W
Mobassaleh M
Donohue-Rolfe A
Balasubramanian K A
Keusch G T
References (36)
36 references, click to expand
  1. A one-step ultramicro method for the assay of intestinal disaccharidases.
    Anal Biochem. 1966 Mar;14(3):376-92 PMID: 5944942
  2. Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine.
    Am J Physiol. 1994 Oct;267(4 Pt 1):G618-24 PMID: 7943326
  3. Morphological and biochemical differentiation in HeLa cells. Effects of cycloheximide on butyrate-induced process formation and ganglioside metabolism.
    Exp Cell Res. 1976 Nov;103(1):55-62 PMID: 186290
  4. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate.
    J Biol Chem. 1978 May 25;253(10):3364-6 PMID: 649576
  5. Induction by butyrate of differentiated properties in cloned murine rhabdomyosarcoma cells.
    Differentiation. 1981;18(2):115-22 PMID: 7215726
  6. A human colonic tumor cell line that maintains vectorial electrolyte transport.
    Am J Physiol. 1984 Feb;246(2 Pt 1):G204-8 PMID: 6141741
  7. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.
    Cancer Res. 1984 Sep;44(9):3961-9 PMID: 6744312
  8. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    J Exp Med. 1984 Dec 1;160(6):1767-81 PMID: 6392471
  9. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines.
    Cancer Res. 1985 Jul;45(7):2976-82 PMID: 4005836
  10. DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts.
    J Biol Chem. 1986 Feb 25;261(6):2786-90 PMID: 2419322
  11. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    J Exp Med. 1986 Jun 1;163(6):1391-404 PMID: 3519828
  12. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.
    J Biol Chem. 1987 Feb 5;262(4):1779-85 PMID: 3543013
  13. Shiga and Shiga-like toxins.
    Microbiol Rev. 1987 Jun;51(2):206-20 PMID: 3299029
  14. Short chain fatty acids in human large intestine, portal, hepatic and venous blood.
    Gut. 1987 Oct;28(10):1221-7 PMID: 3678950
  15. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Eur J Biochem. 1988 Jan 15;171(1-2):45-50 PMID: 3276522
  16. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine.
    J Infect Dis. 1988 May;157(5):1023-31 PMID: 3283253
  17. Effects of 5-azacytidine, sodium butyrate, and phorbol esters on amino acid transport system A in a kidney epithelial cell line, MDCK: evidence for multiple mechanisms of regulation.
    J Cell Physiol. 1988 Oct;137(1):117-24 PMID: 2459137
  18. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.
    J Infect Dis. 1989 May;159(5):881-9 PMID: 2651533
  19. Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes.
    Gastroenterology. 1989 Aug;97(2):384-91 PMID: 2663611
  20. Globotetraosylceramide is recognized by the pig edema disease toxin.
    J Biol Chem. 1989 Jul 25;264(21):12520-5 PMID: 2663859
  21. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Infect Immun. 1989 Dec;57(12):3888-93 PMID: 2807552
  22. Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport.
    J Clin Invest. 1989 Nov;84(5):1509-17 PMID: 2681267
  23. Diversion colitis: a nutritional deficiency syndrome?
    Nutr Rev. 1989 Sep;47(9):257-61 PMID: 2689929
  24. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes.
    J Biol Chem. 1990 Apr 5;265(10):5722-30 PMID: 2180933
  25. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2.
    Gastroenterology. 1990 May;98(5 Pt 1):1199-207 PMID: 2323513
  26. Short chain fatty acid-induced colitis in mice.
    Int J Tissue React. 1989;11(4):165-8 PMID: 2634625
  27. Regulation of distribution, amount and ligand affinity of sugar receptors in human colon carcinoma cells by treatment with sodium butyrate, retinoic acid and phorbol ester.
    Anticancer Res. 1990 Jul-Aug;10(4):1005-12 PMID: 2382971
  28. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones.
    Exp Cell Res. 1990 Sep;190(1):76-84 PMID: 1974861
  29. Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.
    J Cell Biol. 1991 May;113(3):553-62 PMID: 1901867
  30. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.
    Gastroenterology. 1992 Jul;103(1):51-6 PMID: 1612357
  31. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples.
    Infect Immun. 1993 Feb;61(2):534-43 PMID: 8423084
  32. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
    Infect Immun. 1993 Mar;61(3):1098-104 PMID: 8432592
  33. Effects of short chain fatty acids on gut morphology and function.
    Gut. 1994 Jan;35(1 Suppl):S35-8 PMID: 8125387
  34. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    J Infect Dis. 1994 Mar;169(3):538-46 PMID: 8158025
  35. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.
    J Cell Biol. 1994 Jul;126(1):53-64 PMID: 8027186
  36. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells.
    Cell. 1975 Jul;5(3):319-22 PMID: 1056809
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1995-09-00
Pages
1328-35
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC185755
Subset
IM
Grants
NIAID NIH HHS · AI-16242 · United States
NIAID NIH HHS · AI-20325 · United States
NIDDK NIH HHS · DK-39120 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com